We need your mantras for a new project! Share with us.
We are aware of and actively working on an issue where the first page/opening posts of threads with more than one page are not able to be accessed. We hope to have this resolved soon. Thank you for your patience!

News: Lynparza may be able to treat more breast cancers

Lynparza is a PARP inhibitor used to treat breast cancer in people with an inherited BRCA mutation. A small study found that Lynparza could also treat metastatic breast cancer in people with an inherited PALB2 mutation or who have breast cancer that has developed a BRCA mutation over time. This means that many more people might be able to receive Lynparza.

Tagged: